Informa PLC Press Release
09 July 2024
Informa Share Buyback Programme
Update on shareholder returns
Informa PLC ('the Company') (LSE: INF.L), the international B2B Events, Specialist Data, Digital Services and Academic Markets Group today provided an update on its Share Buyback programme
Share Buyback Programme
In February 2022, as part of its commitment to accelerate shareholder returns, Informa announced a share buyback programme of up to £1bn. The buyback programme was extended by £150m on 14 November 2023, a further £250m on 8 March 2024, and an additional £160m on 8 May 2024 taking the total programme to £1.56bn.
As part of the extended share buyback, on 08 July 2024, the Company purchased 581,179 ordinary shares for cancellation through Morgan Stanley & Co. International plc at an average price of 858.13 pence per share. The highest and lowest purchase price paid per share were 864.20 and 852.60 respectively, with the aggregate details of shares purchased by trading venue as outlined in the table below:
Trading venue | Weighted average price paid per share (GBp) | Aggregate number of shares purchased | Lowest price paid per share | Highest price paid per share |
London Stock Exchange | 857.28 | 275,096 | 852.60 | 864.20 |
Chi-X (CXE) | 859.81 | 194,054 | 853.80 | 864.20 |
BATS (BXE) | 857.19 | 68,102 | 853.00 | 864.20 |
AQUIS (AQXE) | 857.47 | 43,927 | 853.00 | 864.20 |
Following settlement of the above purchases and cancellation of the purchased ordinary shares, the Company's total number of ordinary shares in issue, and its total voting rights, will be 1,336,689,473 ordinary shares. The Company does not hold any shares in Treasury.
In accordance with Article 5(1)(b) of the Market Abuse Regulation, a full breakdown of the individual trades made as part of the buyback programme is detailed in the attachment.
http://www.rns-pdf.londonstockexchange.com/rns/5787V_1-2024-7-8.pdf
Enquiries | |
Richard Menzies-Gow, Director of IR & Communications | +44 (0) 20 8052 2787 |
Heledd Hanscomb, Deputy Company Secretary | +44 (0) 20 8052 0661 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.